Dr. Carolin Melati Daamen

Launching new indications and launch preparation - Conceptual design, set-up, supervision of Investigator Sponsored Trials and Non-Interventional Studies - KOL liaison and medical support of clinical phase II/III trials - KOL-Management - Collaborative work/running strategic projects with Global, World Wide Team and US Team - Cross-functional work with Field Medical Team, Marketing, Market Access, Regulatory, Legal,.. - Strategic Medical Planning - Design, planning, coordination and execution of Symposia

Brand Management Immunologie, Sarilumab/Kevzara, Dupilumab, pre-launch Marketing, Disease Awareness Campaign, Multichannel Marketing, Conceptual Design of Congress Booth.

Lipids Cardiovascular – Medical Management Clexane® + Synvisc® - Betreuung Meinungsbildner – Koordination medizinisch-wissenschaftlicher Aktivitäten – Global Brand Team – Cross-funktionale Zusammenarbeit – Zusammenarbeit mit Kardiologen und Orthopäden – Produktkampagnen – Disease Awareness – Advisory Board – Interaktion mit Regulatory – Koordination medizinischer Publikationsaktivitäten, national und international – Konzeption und Durchführung medizin. Schulungen - Biosurgery Market Access Leadership Team.

Achieved a first-author publication (PMID: 22502800). Established an ovalbumin-dependent mouse model of allergic airway inflammation.

Increased work efficiency by managing laboratory organisation, ordering and scheduling equipment. Optimised Western Blots for the study of apoptosis in tumour immunology.

Identified increased fibrosis in mice suffering from arrhythmia. Achieved a publication (PMID: 22368123).

Determined mediators of stroke-induced immunodepression

Investigated the role of regulatory T cells in establishing an immunological tolerance towards the fetus.

Optimised qPCR assay and identified early markers in colorectal cancer

Immunology

Immunologie